-
1
-
-
0031024728
-
Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
-
The International Mycophenolate Mofetil Renal Transplant Study Groups
-
Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C: Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. Transplantation 63: 39-47, 1997
-
(1997)
Transplantation
, vol.63
, pp. 39-47
-
-
Halloran, P.1
Mathew, T.2
Tomlanovich, S.3
Groth, C.4
Hooftman, L.5
Barker, C.6
-
2
-
-
34247238869
-
Kidney and pancreas transplantation in the United States, 1996-2005
-
Anreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS: Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 7: 1359-1375, 2007
-
(2007)
Am J Transplant
, vol.7
, pp. 1359-1375
-
-
Anreoni, K.A.1
Brayman, K.L.2
Guidinger, M.K.3
Sommers, C.M.4
Sung, R.S.5
-
4
-
-
65549153182
-
Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review
-
Knight SR, Russell NK, Barcena L: Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: A systematic review. Transplantation 87: 785-794, 2009
-
(2009)
Transplantation
, vol.87
, pp. 785-794
-
-
Knight, S.R.1
Russell, N.K.2
Barcena, L.3
-
5
-
-
0038246498
-
Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies
-
DOI 10.1034/j.1600-6143.2003.00079.x
-
Shaw LM, Korecka M, Venkataramanan R, Goldberg L, Bloom R, Brayman KL: Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant 3: 534-542, 2003 (Pubitemid 36612836)
-
(2003)
American Journal of Transplantation
, vol.3
, Issue.5
, pp. 534-542
-
-
Shaw, L.M.1
Korecka, M.2
Venkataramanan, R.3
Goldberg, L.4
Bloom, R.5
Brayman, K.L.6
-
6
-
-
0033609476
-
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation
-
van Gelder T, Hilbrands LB, Vanrenterghem Y, Weimar W, de Fijter JW, Squifflet JP, Hené RJ, Verpooten GA, Navarro MT, Hale MD, Nicholls AJ: A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 68: 261-266, 1999
-
(1999)
Transplantation
, vol.68
, pp. 261-266
-
-
Van Gelder, T.1
Hilbrands, L.B.2
Vanrenterghem, Y.3
Weimar, W.4
De Fijter, J.W.5
Squifflet, J.P.6
Hené, R.J.7
Verpooten, G.A.8
Navarro, M.T.9
Hale, M.D.10
Nicholls, A.J.11
-
7
-
-
55949130835
-
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: The fixed-dose concentration-controlled trial
-
van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD: Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: The fixed-dose concentration-controlled trial. Transplantation 86: 1043-1051, 2008
-
(2008)
Transplantation
, vol.86
, pp. 1043-1051
-
-
Van Gelder, T.1
Silva, H.T.2
De Fijter, J.W.3
Budde, K.4
Kuypers, D.5
Tyden, G.6
Lohmus, A.7
Sommerer, C.8
Hartmann, A.9
Le Meur, Y.10
Oellerich, M.11
Holt, D.W.12
Tönshoff, B.13
Keown, P.14
Campbell, S.15
Mamelok, R.D.16
-
8
-
-
35248839494
-
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves outcomes after renal transplantation
-
Le Meur Y, Büchler M, Thierry A, Caillard S, Villemain F, Lavaud S, Etienne I, Westeel PF, Hurault de Ligny B, Rostaing L, Thervet E, Szelag JC, Rérolle JP, Rousseau A, Touchard G, Marquet P: Individualized mycophenolate mofetil dosing based on drug exposure significantly improves outcomes after renal transplantation. Am J Transplant 7: 2496-2503, 2007
-
(2007)
Am J Transplant
, vol.7
, pp. 2496-2503
-
-
Le Meur, Y.1
Büchler, M.2
Thierry, A.3
Caillard, S.4
Villemain, F.5
Lavaud, S.6
Etienne, I.7
Westeel, P.F.8
Hurault De Ligny, B.9
Rostaing, L.10
Thervet, E.11
Szelag, J.C.12
Rérolle, J.P.13
Rousseau, A.14
Touchard, G.15
Marquet, P.16
-
9
-
-
3042743984
-
Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation
-
DOI 10.1111/j.1600-6143.2004.00455.x
-
Kiberd BA, Lawen J, Fraser AD, Keough-Ryan T, Belitsky P: Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation. Am J Transplant 4: 1079-1083, 2004 (Pubitemid 38868597)
-
(2004)
American Journal of Transplantation
, vol.4
, Issue.7
, pp. 1079-1083
-
-
Kiberd, B.A.1
Lawen, J.2
Fraser, A.D.3
Keough-Ryan, T.4
Belitsky, P.5
-
10
-
-
21844466718
-
Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period
-
DOI 10.1016/j.transproceed.2005.03.059, PII S0041134505002976
-
Kiberd BA, Puthenparumpil JJ, Fraser A, Tett SE, Lawen J: Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplant Proc 37: 2320-2323, 2005 (Pubitemid 40956441)
-
(2005)
Transplantation Proceedings
, vol.37
, Issue.5
, pp. 2320-2323
-
-
Kiberd, B.A.1
Puthenparumpil, J.J.2
Fraser, A.3
Tett, S.E.4
Lawen, J.5
-
11
-
-
0036721306
-
Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus
-
Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM: Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem 48: 1497-1504, 2002 (Pubitemid 34925784)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.9
, pp. 1497-1504
-
-
Pawinski, T.1
Hale, M.2
Korecka, M.3
Fitzsimmons, W.E.4
Shaw, L.M.5
-
12
-
-
33847761900
-
Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN')
-
Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7: 518-526, 2007
-
(2007)
Am J Transplant
, vol.7
, pp. 518-526
-
-
Solez, K.1
Colvin, R.B.2
Racusen, L.C.3
Sis, B.4
Halloran, P.F.5
Birk, P.E.6
Campbell, P.M.7
Cascalho, M.8
Collins, A.B.9
Demetris, A.J.10
Drachenberg, C.B.11
Gibson, I.W.12
Grimm, P.C.13
Haas, M.14
Lerut, E.15
Liapis, H.16
Mannon, R.B.17
Marcus, P.B.18
Mengel, M.19
Mihatsch, M.J.20
Nankivell, B.J.21
Nickeleit, V.22
Papadimitriou, J.C.23
Platt, J.L.24
Randhawa, P.25
Roberts, I.26
Salinas-Madriga, L.27
Salomon, D.R.28
Seron, D.29
Sheaff, M.30
Weening, J.J.31
more..
-
13
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
14
-
-
0031786415
-
Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay
-
Beal JL, Jones CE, Taylor PJ, Tett SE: Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay. Ther Drug Monit 20: 685-690, 1998
-
(1998)
Ther Drug Monit
, vol.20
, pp. 685-690
-
-
Beal, J.L.1
Jones, C.E.2
Taylor, P.J.3
Tett, S.E.4
-
15
-
-
33645450634
-
Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients
-
van Hest RM, Mathot RA, Pescovitz MD, Gordon R, Mamelok RD, van Gelder T: Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients. J Am Soc Nephrol 17: 871-880, 2006
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 871-880
-
-
Van Hest, R.M.1
Mathot, R.A.2
Pescovitz, M.D.3
Gordon, R.4
Mamelok, R.D.5
Van Gelder, T.6
-
16
-
-
65749114832
-
Proton pump inhibitor co-medication reduces mycophenolate acid exposure in heart transplant recipients
-
Kofler S, Deutsch M, Bigdeli AK, Shvets N, Vogeser M, Mueller TH, Meiser B, Steinbeck G, Reichart B, Kaczmarek I: Proton pump inhibitor co-medication reduces mycophenolate acid exposure in heart transplant recipients. J Heart Lung Transplant 28: 605-611, 2009
-
(2009)
J Heart Lung Transplant
, vol.28
, pp. 605-611
-
-
Kofler, S.1
Deutsch, M.2
Bigdeli, A.K.3
Shvets, N.4
Vogeser, M.5
Mueller, T.H.6
Meiser, B.7
Steinbeck, G.8
Reichart, B.9
Kaczmarek, I.10
-
17
-
-
2042515610
-
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients
-
DOI 10.1016/j.clpt.2003.12.009, PII S0009923603007707
-
Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y: Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients. Clin Pharmacol Ther 75: 434-447, 2004 (Pubitemid 38534564)
-
(2004)
Clinical Pharmacology and Therapeutics
, vol.75
, Issue.5
, pp. 434-447
-
-
Kuypers, D.R.J.1
Claes, K.2
Evenepoel, P.3
Maes, B.4
Vanrenterghem, Y.5
-
18
-
-
77949385812
-
Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid
-
van Gelder T, Tedesco Silva H, de Fijter JW, Budde K, Kuypers D, Arns W, Paul Soulillou J, Kanellis J, Zelvys A, Ekberg H, Holzer H, Rostaing L, Mamelok RD: Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid. Transplantation 89: 595-599, 2010
-
(2010)
Transplantation
, vol.89
, pp. 595-599
-
-
Van Gelder, T.1
Tedesco Silva, H.2
De Fijter, J.W.3
Budde, K.4
Kuypers, D.5
Arns, W.6
Paul Soulillou, J.7
Kanellis, J.8
Zelvys, A.9
Ekberg, H.10
Holzer, H.11
Rostaing, L.12
Mamelok, R.D.13
-
19
-
-
37349034394
-
ELITE Symphony Study: Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, Margreiter R, Hugo C, Grinyó JM, Frei U, Vanrenterghem Y, Daloze P, Halloran PF; ELITE Symphony Study: Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357: 2562-2575, 2007
-
(2007)
N Engl J Med
, vol.357
, pp. 2562-2575
-
-
Ekberg, H.1
Tedesco-Silva, H.2
Demirbas, A.3
Vítko, S.4
Nashan, B.5
Gürkan, A.6
Margreiter, R.7
Hugo, C.8
Grinyó, J.M.9
Frei, U.10
Vanrenterghem, Y.11
Daloze, P.12
Halloran, P.F.13
-
20
-
-
0742322211
-
Interleukin 2 receptor antagonists for renal transplantation recipients: A meta-analysis of randomized trials
-
DOI 10.1097/01.TP.0000109643.32659.C4
-
Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC: Interleukin 2 receptor antagonists for renal transplant recipients: A meta-analysis of randomized trials. Transplantation 77: 166-176, 2004 (Pubitemid 38155741)
-
(2004)
Transplantation
, vol.77
, Issue.2
, pp. 166-176
-
-
Webster, A.C.1
Playford, E.G.2
Higgins, G.3
Chapman, J.R.4
Craig, J.C.5
|